Effects of Vibration Training on Exercise Capacity in COPD-patients
Overview
The aim of this study is to investigate the exercise capacity in COPD-patients performing a vibration training additional to a standard three-week rehabilitation program in comparison to patients performing merely a rehabilitation program.
Full Title of Study: “Effects of Vibration Training During a Three-week Rehabilitation on Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD) III/IV-Patients”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: April 2011
Interventions
- Other: whole body vibration training
- performing squats for 3×3 minutes while using vibration platform three times a week
Arms, Groups and Cohorts
- Experimental: Rehabilitation with vibration training
- No Intervention: Rehabilitation without vibration training
Clinical Trial Outcome Measures
Primary Measures
- 6-Minute-Walking-Distance
- Time Frame: day 1, day 19
- Change in 6-minute-walking-distance from baseline to day 19
Secondary Measures
- Body Composition
- Time Frame: day 1 and 19
- Change in body composition from baseline to day 19
- Isometric Maximum Handgrip Force
- Time Frame: day 1, day 19
- change in isometric max. handgrip force from baseline to day 19
- BODE-Score
- Time Frame: day 1, day 19
- Change in Bode-Score from baseline to day 19
- Lung Function
- Time Frame: day 1
- Arterial Blood Gas
- Time Frame: day 1
- Brain Natruretic Peptide (BNP)
- Time Frame: day 1, day 19
- change in BNP from baseline to day 19
Participating in This Clinical Trial
Inclusion Criteria
- Chronic obstructive pulmonary disease III/IV Exclusion Criteria:
- Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics)) – Severe disease other than COPD, that could influence the results of the study – Abuse of alcohol or drugs – Simultaneously participation in another study – Tachypnea (>30/min) – Severe exacerbation during rehabilitation – Cardiac insufficiency (NYHA IV) – Myocardial infarction during the last 6 weeks – Mental-health problem – Pregnancy – Known HIV-infection – Slipped disk – Acute discopathy – Acute thrombosis – Implants in trained regions of the body (lower extremities) – Acute inflammation of the locomotor system, active arthrosis or rheumatoid arthritis – Acute tendinopathy in trained regions of the body – Acute hernia – Fresh fractures, wounds or scars in trained regions of the body – Gallstones or stones in the urinary tract collection system
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 75 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Schön Klinik Berchtesgadener Land
- Provider of Information About this Clinical Study
- Principal Investigator: Klaus Kenn, MD – Schön Klinik Berchtesgadener Land
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.